Learn more

JANSSEN PHARMACEUTICALS INC

Overview
  • Total Patents
    785
  • GoodIP Patent Rank
    2,925
  • Filing trend
    ⇧ 43.0%
About

JANSSEN PHARMACEUTICALS INC has a total of 785 patent applications. It increased the IP activity by 43.0%. Its first patent ever was published in 2002. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are PHARMAXIS LTD, KAKEN PHARMACEUTICAL CO LTD and THERAVANCE BIOPHARMA ANTIBIOTICS IP LLC.

Patent filings per year

Chart showing JANSSEN PHARMACEUTICALS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Marchand Arnaud Didier M 186
#2 Kesteleyn Bart Rudolf Romanie 185
#3 Raboisson Pierre Jean-Marie Bernard 181
#4 Bonfanti Jean-François 117
#5 Bardiot Dorothée Alice Marie-Eve 105
#6 Jonckers Tim Hugo Maria 99
#7 Macdonald Gregor James 91
#8 Gijsen Henricus Jacobus Maria 78
#9 Trabanco-Suarez Andres Avelino 67
#10 Bardiot Dorothee Alice Marie-Eve 60

Latest patents

Publication Filing date Title
WO2021059214A1 Drug administration system configured to determine a drug dosing scheme
WO2021059212A1 Drug delivery device incorporating electrical system contamination protection, power source management, power source monitoring, and/or power source operation
WO2021059211A1 Drug delivery adjustment
WO2021059202A1 Drug administration device and system for establishing a dosage regimen and compatibility of components
WO2021059210A1 Interconnection of drug administration systems
WO2021059200A1 Drug delivery systems and methods
WO2021059213A1 Measuring parameters associated with drug administration and drug administration devices incorporating same
WO2021059203A1 Drug administration devices that communicate with external systems and/or other devices
WO2021059201A1 Remote aggregation of data for drug administration devices
WO2021038500A2 Esketamine for the treatment of patients with major depressive disorder, including suicidality
WO2021038480A1 Combinations for treating influenza virus
US2021030967A1 Injection Device with Ergonomic Housing Form Factor
WO2021014405A1 Learning platform for patient journey mapping
US2020397795A1 Prophylactic treatment of venous thromboembolism
US2020339643A1 Heterologous administration of tau vaccines
WO2020256820A1 Formulations of azaindole compounds
US2020332297A1 Combination therapy for treating hepatitis b virus infection
WO2020214976A1 Combination therapy for treating hepatitis b virus infection
TW202102670A Methods of producing bioconjugates of e. coli o-antigen polysaccharides, compositions thereof, and methods of use thereof
WO2020191082A1 Bioconjugates of e. coli o-antigen polysaccharides, methods of production thereof, and methods of use thereof